DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $345,000 | -1.1% | 4,023 | -2.8% | 0.03% | +7.4% |
Q2 2017 | $349,000 | +10.4% | 4,137 | +11.6% | 0.03% | +12.5% |
Q1 2017 | $316,000 | +5.0% | 3,707 | +3.1% | 0.02% | +4.3% |
Q4 2016 | $301,000 | -1.0% | 3,594 | -7.5% | 0.02% | -4.2% |
Q3 2016 | $304,000 | -49.7% | 3,887 | -47.9% | 0.02% | -48.9% |
Q2 2016 | $604,000 | -16.7% | 7,466 | -0.0% | 0.05% | -25.4% |
Q1 2016 | $725,000 | -12.3% | 7,469 | -23.2% | 0.06% | -7.4% |
Q4 2015 | $827,000 | +128.5% | 9,722 | +157.1% | 0.07% | +106.1% |
Q3 2015 | $362,000 | +6.2% | 3,781 | +1.0% | 0.03% | +6.5% |
Q2 2015 | $341,000 | +1.8% | 3,744 | -8.0% | 0.03% | +3.3% |
Q1 2015 | $335,000 | -99.9% | 4,069 | -35.3% | 0.03% | -21.1% |
Q4 2014 | $533,053,000 | +114044.1% | 6,286 | +1.0% | 0.04% | +5.6% |
Q3 2014 | $467,000 | -20.7% | 6,226 | -16.8% | 0.04% | -21.7% |
Q2 2014 | $589,000 | +8.3% | 7,479 | +3.7% | 0.05% | -2.1% |
Q1 2014 | $544,000 | -3.7% | 7,212 | -1.3% | 0.05% | -6.0% |
Q4 2013 | $565,000 | +11.0% | 7,310 | 0.0% | 0.05% | +2.0% |
Q3 2013 | $509,000 | +55.7% | 7,310 | +41.5% | 0.05% | +22.5% |
Q2 2013 | $327,000 | – | 5,166 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |